The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enuresis Treatment Drugs Market Research Report 2025
Synopsis
The global Enuresis Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enuresis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enuresis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Enuresis Treatment Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Enuresis Treatment Drugs include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Guangdong Xianqiang Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enuresis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enuresis Treatment Drugs.
The Enuresis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enuresis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enuresis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
Segment by Type
Desmopressin(DDAVP)
Tofranil
Others
Segment by Application
Hospital
Specialist Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enuresis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Enuresis Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enuresis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enuresis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Enuresis Treatment Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Enuresis Treatment Drugs include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Guangdong Xianqiang Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enuresis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enuresis Treatment Drugs.
The Enuresis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enuresis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enuresis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
Segment by Type
Desmopressin(DDAVP)
Tofranil
Others
Segment by Application
Hospital
Specialist Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enuresis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enuresis Treatment Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Desmopressin(DDAVP)
1.2.3 Tofranil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Enuresis Treatment Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enuresis Treatment Drugs Market Perspective (2019-2030)
2.2 Global Enuresis Treatment Drugs Growth Trends by Region
2.2.1 Global Enuresis Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Enuresis Treatment Drugs Historic Market Size by Region (2019-2024)
2.2.3 Enuresis Treatment Drugs Forecasted Market Size by Region (2025-2030)
2.3 Enuresis Treatment Drugs Market Dynamics
2.3.1 Enuresis Treatment Drugs Industry Trends
2.3.2 Enuresis Treatment Drugs Market Drivers
2.3.3 Enuresis Treatment Drugs Market Challenges
2.3.4 Enuresis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enuresis Treatment Drugs Players by Revenue
3.1.1 Global Top Enuresis Treatment Drugs Players by Revenue (2019-2024)
3.1.2 Global Enuresis Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Enuresis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Enuresis Treatment Drugs Revenue
3.4 Global Enuresis Treatment Drugs Market Concentration Ratio
3.4.1 Global Enuresis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enuresis Treatment Drugs Revenue in 2023
3.5 Global Key Players of Enuresis Treatment Drugs Head office and Area Served
3.6 Global Key Players of Enuresis Treatment Drugs, Product and Application
3.7 Global Key Players of Enuresis Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Enuresis Treatment Drugs Breakdown Data by Type
4.1 Global Enuresis Treatment Drugs Historic Market Size by Type (2019-2024)
4.2 Global Enuresis Treatment Drugs Forecasted Market Size by Type (2025-2030)
5 Enuresis Treatment Drugs Breakdown Data by Application
5.1 Global Enuresis Treatment Drugs Historic Market Size by Application (2019-2024)
5.2 Global Enuresis Treatment Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Enuresis Treatment Drugs Market Size (2019-2030)
6.2 North America Enuresis Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Enuresis Treatment Drugs Market Size by Country (2019-2024)
6.4 North America Enuresis Treatment Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enuresis Treatment Drugs Market Size (2019-2030)
7.2 Europe Enuresis Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Enuresis Treatment Drugs Market Size by Country (2019-2024)
7.4 Europe Enuresis Treatment Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enuresis Treatment Drugs Market Size (2019-2030)
8.2 Asia-Pacific Enuresis Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Enuresis Treatment Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Enuresis Treatment Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enuresis Treatment Drugs Market Size (2019-2030)
9.2 Latin America Enuresis Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Enuresis Treatment Drugs Market Size by Country (2019-2024)
9.4 Latin America Enuresis Treatment Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enuresis Treatment Drugs Market Size (2019-2030)
10.2 Middle East & Africa Enuresis Treatment Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Enuresis Treatment Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Enuresis Treatment Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Enuresis Treatment Drugs Introduction
11.1.4 Allergan Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Ferring Pharmaceuticals, Inc.
11.2.1 Ferring Pharmaceuticals, Inc. Company Details
11.2.2 Ferring Pharmaceuticals, Inc. Business Overview
11.2.3 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Introduction
11.2.4 Ferring Pharmaceuticals, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.2.5 Ferring Pharmaceuticals, Inc. Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Enuresis Treatment Drugs Introduction
11.3.4 Pfizer Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.3.5 Pfizer Inc. Recent Development
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Company Details
11.4.2 Janssen Pharmaceuticals, Inc. Business Overview
11.4.3 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Introduction
11.4.4 Janssen Pharmaceuticals, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.4.5 Janssen Pharmaceuticals, Inc. Recent Development
11.5 Urovant Sciences, Inc.
11.5.1 Urovant Sciences, Inc. Company Details
11.5.2 Urovant Sciences, Inc. Business Overview
11.5.3 Urovant Sciences, Inc. Enuresis Treatment Drugs Introduction
11.5.4 Urovant Sciences, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.5.5 Urovant Sciences, Inc. Recent Development
11.6 Astellas Pharma US, Inc.
11.6.1 Astellas Pharma US, Inc. Company Details
11.6.2 Astellas Pharma US, Inc. Business Overview
11.6.3 Astellas Pharma US, Inc. Enuresis Treatment Drugs Introduction
11.6.4 Astellas Pharma US, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.6.5 Astellas Pharma US, Inc. Recent Development
11.7 Bayer Corp
11.7.1 Bayer Corp Company Details
11.7.2 Bayer Corp Business Overview
11.7.3 Bayer Corp Enuresis Treatment Drugs Introduction
11.7.4 Bayer Corp Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.7.5 Bayer Corp Recent Development
11.8 Mallinckrodt, Inc.
11.8.1 Mallinckrodt, Inc. Company Details
11.8.2 Mallinckrodt, Inc. Business Overview
11.8.3 Mallinckrodt, Inc. Enuresis Treatment Drugs Introduction
11.8.4 Mallinckrodt, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.8.5 Mallinckrodt, Inc. Recent Development
11.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
11.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Details
11.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
11.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Introduction
11.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Development
11.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
11.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Company Details
11.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
11.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Introduction
11.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Development
11.11 Beijing Zizhu Pharmaceutical Co., Ltd
11.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Company Details
11.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Introduction
11.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Recent Development
11.12 Shanghai Pharmaceutical Group
11.12.1 Shanghai Pharmaceutical Group Company Details
11.12.2 Shanghai Pharmaceutical Group Business Overview
11.12.3 Shanghai Pharmaceutical Group Enuresis Treatment Drugs Introduction
11.12.4 Shanghai Pharmaceutical Group Revenue in Enuresis Treatment Drugs Business (2019-2024)
11.12.5 Shanghai Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Enuresis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Desmopressin(DDAVP)
Table 3. Key Players of Tofranil
Table 4. Key Players of Others
Table 5. Global Enuresis Treatment Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Enuresis Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Enuresis Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Enuresis Treatment Drugs Market Share by Region (2019-2024)
Table 9. Global Enuresis Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Enuresis Treatment Drugs Market Share by Region (2025-2030)
Table 11. Enuresis Treatment Drugs Market Trends
Table 12. Enuresis Treatment Drugs Market Drivers
Table 13. Enuresis Treatment Drugs Market Challenges
Table 14. Enuresis Treatment Drugs Market Restraints
Table 15. Global Enuresis Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Enuresis Treatment Drugs Market Share by Players (2019-2024)
Table 17. Global Top Enuresis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enuresis Treatment Drugs as of 2023)
Table 18. Ranking of Global Top Enuresis Treatment Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Enuresis Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Enuresis Treatment Drugs, Headquarters and Area Served
Table 21. Global Key Players of Enuresis Treatment Drugs, Product and Application
Table 22. Global Key Players of Enuresis Treatment Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Enuresis Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Enuresis Treatment Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Enuresis Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Enuresis Treatment Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Enuresis Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Enuresis Treatment Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Enuresis Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Enuresis Treatment Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Enuresis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Enuresis Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Enuresis Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Enuresis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Enuresis Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Enuresis Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Enuresis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Enuresis Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Enuresis Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Enuresis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Enuresis Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Enuresis Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Enuresis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Enuresis Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Enuresis Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Allergan Company Details
Table 48. Allergan Business Overview
Table 49. Allergan Enuresis Treatment Drugs Product
Table 50. Allergan Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. Ferring Pharmaceuticals, Inc. Company Details
Table 53. Ferring Pharmaceuticals, Inc. Business Overview
Table 54. Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Product
Table 55. Ferring Pharmaceuticals, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 56. Ferring Pharmaceuticals, Inc. Recent Development
Table 57. Pfizer Inc. Company Details
Table 58. Pfizer Inc. Business Overview
Table 59. Pfizer Inc. Enuresis Treatment Drugs Product
Table 60. Pfizer Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 61. Pfizer Inc. Recent Development
Table 62. Janssen Pharmaceuticals, Inc. Company Details
Table 63. Janssen Pharmaceuticals, Inc. Business Overview
Table 64. Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Product
Table 65. Janssen Pharmaceuticals, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 66. Janssen Pharmaceuticals, Inc. Recent Development
Table 67. Urovant Sciences, Inc. Company Details
Table 68. Urovant Sciences, Inc. Business Overview
Table 69. Urovant Sciences, Inc. Enuresis Treatment Drugs Product
Table 70. Urovant Sciences, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 71. Urovant Sciences, Inc. Recent Development
Table 72. Astellas Pharma US, Inc. Company Details
Table 73. Astellas Pharma US, Inc. Business Overview
Table 74. Astellas Pharma US, Inc. Enuresis Treatment Drugs Product
Table 75. Astellas Pharma US, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 76. Astellas Pharma US, Inc. Recent Development
Table 77. Bayer Corp Company Details
Table 78. Bayer Corp Business Overview
Table 79. Bayer Corp Enuresis Treatment Drugs Product
Table 80. Bayer Corp Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 81. Bayer Corp Recent Development
Table 82. Mallinckrodt, Inc. Company Details
Table 83. Mallinckrodt, Inc. Business Overview
Table 84. Mallinckrodt, Inc. Enuresis Treatment Drugs Product
Table 85. Mallinckrodt, Inc. Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 86. Mallinckrodt, Inc. Recent Development
Table 87. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Details
Table 88. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
Table 89. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product
Table 90. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 91. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Development
Table 92. Guangdong Xianqiang Pharmaceutical Co., Ltd Company Details
Table 93. Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
Table 94. Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product
Table 95. Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 96. Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Development
Table 97. Beijing Zizhu Pharmaceutical Co., Ltd Company Details
Table 98. Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
Table 99. Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product
Table 100. Beijing Zizhu Pharmaceutical Co., Ltd Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 101. Beijing Zizhu Pharmaceutical Co., Ltd Recent Development
Table 102. Shanghai Pharmaceutical Group Company Details
Table 103. Shanghai Pharmaceutical Group Business Overview
Table 104. Shanghai Pharmaceutical Group Enuresis Treatment Drugs Product
Table 105. Shanghai Pharmaceutical Group Revenue in Enuresis Treatment Drugs Business (2019-2024) & (US$ Million)
Table 106. Shanghai Pharmaceutical Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Enuresis Treatment Drugs Picture
Figure 2. Global Enuresis Treatment Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enuresis Treatment Drugs Market Share by Type: 2023 VS 2030
Figure 4. Desmopressin(DDAVP) Features
Figure 5. Tofranil Features
Figure 6. Others Features
Figure 7. Global Enuresis Treatment Drugs Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Enuresis Treatment Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Specialist Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Enuresis Treatment Drugs Report Years Considered
Figure 13. Global Enuresis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Enuresis Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Enuresis Treatment Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Enuresis Treatment Drugs Market Share by Players in 2023
Figure 17. Global Top Enuresis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enuresis Treatment Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Enuresis Treatment Drugs Revenue in 2023
Figure 19. North America Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Enuresis Treatment Drugs Market Share by Country (2019-2030)
Figure 21. United States Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Enuresis Treatment Drugs Market Share by Country (2019-2030)
Figure 25. Germany Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Enuresis Treatment Drugs Market Share by Region (2019-2030)
Figure 33. China Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Enuresis Treatment Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Enuresis Treatment Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Enuresis Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Allergan Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 49. Ferring Pharmaceuticals, Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 50. Pfizer Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 51. Janssen Pharmaceuticals, Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 52. Urovant Sciences, Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 53. Astellas Pharma US, Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 54. Bayer Corp Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 55. Mallinckrodt, Inc. Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 56. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 57. Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 58. Beijing Zizhu Pharmaceutical Co., Ltd Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 59. Shanghai Pharmaceutical Group Revenue Growth Rate in Enuresis Treatment Drugs Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
